Clinical Features of Varicella-Zoster Virus Infection
Abstract
:1. Introduction
2. Varicella and Its Complications
3. Herpes Zoster
Postherpetic Neuralgia (PHN)
4. Neurological Complications of VZV Reactivation
4.1. VZV Vasculopathy
4.2. Giant Cell Arteritis and VZV
4.3. Segmental Weakness and Myelopathy
4.4. VZV Encephalitis
4.5. VZV Cranial Neuropathies
4.6. VZV and Guillain–Barré Syndrome (GBS)
4.7. Zoster Sine Herpete
5. VZV and Enteric Complications
6. VZV Vaccinations
Author Contributions
Funding
Conflicts of Interest
References
- Gershon, A.A.; Breuer, J.; Cohen, J.I.; Cohrs, R.J.; Gershon, M.D.; Gilden, D.; Grose, C.; Hambleton, S.; Kennedy, P.G.E.; Oxman, M.; et al. Varicella zoster virus infection. Nat. Rev. Dis Prim. 2015, 1, 15016. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kennedy, P.G.E. Varicella-zoster virus latency in human ganglia. Rev. Med. Virol. 2002, 12, 327–334. [Google Scholar] [CrossRef] [PubMed]
- Nagel, M.A.; Gilden, D.H. The protean neurologic manifestations of varicella-zoster virus. Cleve Clin. J. Med. 2007, 74, 489–504. [Google Scholar] [CrossRef] [PubMed]
- Burke, B.L.; Steele, R.W.; Beard, O.W.; Wood, J.S.; Cain, T.D.; Marmer, D.J. Immune responses to varicella-zoster in the aged. Arch. Intern. Med. 1982, 142, 291–293. [Google Scholar] [CrossRef] [PubMed]
- Berger, R.; Luescher, D.; Just, M. Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine. J. Infect. Dis. 1984, 149, 647. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G.E.; Cohrs, R.J. Varicella-zoster virus human ganglionic latency: A current summary. J. Neurovirol. 2010, 16, 411–418. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G.E.; Grinfield, E.; Gow, J.W. Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia. Proc. Natl. Acad. Sci. USA. 1998, 95, 4658–4662. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Clarke, P.; Beer, T.; Gilden, D.H. Configuration and terminal sequences of the simian varicella virus. Virology 1995, 207, 154–159. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G.E.; Rovnak, J.; Badani, H.; Cohrs, R.J. A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J. Gen. Virol. 2015, 96 Pt 7, 1581–1602. [Google Scholar] [CrossRef]
- Cohrs, R.J.; Barbour, M.; Gilden, D.H. Varicella-zoster virus (VZV) transcription during latency in human ganglia: Detection of transcripts to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J. Virol. 1996, 70, 2789–2796. [Google Scholar] [PubMed]
- Kennedy, P.G.E.; Grinfeld, E.; Bell, J.E. Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J. Virol. 2000, 74, 11893–11898. [Google Scholar] [CrossRef] [PubMed]
- Cohrs, R.J.; Gilden, D.H. Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia. J. Virol. 2007, 81, 2950–2956. [Google Scholar] [CrossRef] [PubMed]
- Cohrs, R.J.; Gilden, D.H.; Kinchington, P.R.; Grinfeld, E.; Kennedy, P.G.E. Varicella-Zoster Virus Gene 66 Transcription and Translation in Latently Infected Human Ganglia. J. Virol. 2003, 77, 6660–6665. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ouwendijk, W.J.; Choe, A.; Nagel, M.A.; Gilden, D.; Osterhaus, A.D.; Cohrs, R.J.; Verjans, G.M. Restricted varicella-zoster virus transcription in human trigeminal ganglia obtained soon after death. J. Virol. 2012, 86, 10203–10206. [Google Scholar] [CrossRef] [PubMed]
- Nagel, M.A.; Choe, A.; Traktinskiy, I.; Cordery-Cotter, R.; Gilden, D.; Cohrs, R.J. Varicella-zoster virus transcriptome in latently infected human ganglia. J. Virol. 2011, 85, 2276–2287. [Google Scholar] [CrossRef] [PubMed]
- Gershon, A.A.; Chen, J.; Davis, L.; Krinsky, C.; Cowles, R.; Reichard, R.; Gershon, M. Latency of varicella zoster virus in dorsal root, cranial, and enteric ganglia in vaccinated children. Trans. Am. Clin. Clim. Assoc. 2012, 123, 17–33. [Google Scholar]
- Depledge, D.P.; Ouwendijk, W.J.D.; Sadaoka, T.; Braspenning, S.E.; Mori, Y.; Cohrs, R.J.; Verjanans, G.; Breuer, J. A spliced latency-associated VZV transcript maps antisense to the viral transactivator gene 61. Nat. Commun. 2018, 9, 1167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gershon, A.A.; Chen, J.; Gershon, M.D. Use of saliva to identify varicella-zoster virus (VZV) infection of the gut. Clin. Infect. Dis. 2015, 61, 536–544. [Google Scholar] [CrossRef] [PubMed]
- Nagel, M.A.; Gilden, D. Update on varicella zoster virus vasculopathy. Curr. Infect. Dis. Rep. 2014, 16, 407. [Google Scholar] [CrossRef] [PubMed]
- Gershon, A.; Takahashi, M.; Seward, J.F. Vaccines. In Varicella; Plotkin, S., Orenstein, W., Offit, P., Eds.; WB Saunders: Philadelphia, PA, USA, 2013; pp. 837–869. [Google Scholar]
- Arvin, A.; Gilden, D. Varicella-Zoster Virus. In Fields Virology; Knipe, D., Howley, P., Eds.; Lippincott, Williams, and Wilkins: Philadelphia, PA, USA, 2013; pp. 2015–2057. [Google Scholar]
- Hope-Simpson, R.E. The nature of herpes zoster: A long term study and a new hypothesis. Proc. R. Soc. Med. 1965, 58, 9–20. [Google Scholar] [PubMed]
- Mehta, S.K.; Cohrs, R.J.; Forghani, B.; Zerbe, G.; Gilden, D.H.; Pierson, D.L. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J. Med. Virol. 2004, 72, 174–179. [Google Scholar] [CrossRef] [PubMed]
- Cohrs, R.J.; Mehta, S.K.; Schmid, D.S.; Gilden, D.H.; Pierson, D.L. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J. Med. Virol. 2008, 80, 1116–1122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gilden, D.H.; Cohrs, R.J.; Mahalingam, R. VZV vasculopathy and postherpetic neuralgia: Progress and perspective on antiviral therapy. Neurology 2005, 64, 21–25. [Google Scholar] [CrossRef] [PubMed]
- Quan, D.; Hammack, B.N.; Kittelson, J.; Gilden, D.H. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch. Neurol. 2006, 63, 940–942. [Google Scholar] [CrossRef] [PubMed]
- Dworkin, R.H.; Johnson, R.W.; Breuer, J.; Gnann, J.W.; Levin, M.J.; Backonja, M.; Betts, R.F.; Gershon, A.A.; Haanpaa, M.L.; McKendrick, M.W.; et al. Recommendations for the management of herpes zoster. Clin. Infect. Dis. 2007, 44 (Suppl. 1), S1–S26. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G.E. Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV). Neurotherapeutics 2016, 13, 509–513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gershon, A.A.; Gershon, M. Varicella Zoster Virus and Giant Cell Arteritis. J. Infect. Dis. 2016, 213, 1859–1861. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gilden, D.; White, T.; Khmeleva, N.; Heintzman, A.; Choe, A.; Boyer, P.J.; Grose, C.; Carpenter, J.E.; Rempel, A.; Bos, N.; et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology 2015, 84, 1948–1955. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nagel, M.A.; White, T.; Khmeleva, N.; Rempel, A.; Boyer, P.J.; Bennett, J.L.; Haller, A.; Lear-Kaul, K.; Kandasmy, B.; Amato, M.; et al. Analysis of Varicella-Zoster Virus in Temporal Arteries Biopsy Positive and Negative for Giant Cell Arteritis. JAMA Neurol. 2015, 72, 1281–1287. [Google Scholar] [CrossRef] [PubMed]
- Buckingham, E.M.; Foley, M.A.; Grose, C.; Syed, N.A.; Smith, M.E.; Margolis, T.P.; THurtell, M.J.; Kardon, R. Identification of Herpes Zoster-Associated Temporal Arteritis Among Cases of Giant Cell Arteritis. Am. J. Ophthalmol. 2018, 187, 51–60. [Google Scholar] [CrossRef] [PubMed]
- Pisapia, D.J.; Lavi, E. VZV, temporal arteritis, and clinical practice: False positive immunohistochemical detection due to antibody cross-reactivity. Exp. Mol. Pathol. 2016, 100, 114–115. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G.E.; Lipton, H.L. Varicella-zoster virus claims yet another painful scalp—Giant cell arteritis. Neurology 2015, 84, 1918–1919. [Google Scholar] [CrossRef] [PubMed]
- Lotan, I.; Steiner, I. Giant cell arteritis following varicella zoster vaccination. J. Neurol. Sci. 2017, 375, 158–159. [Google Scholar] [CrossRef] [PubMed]
- Gilden, D.; Nagel, M.A.; Cohrs, R.J. Varicella-zoster. Handb. Clin. Neurol. 2014, 123, 265–283. [Google Scholar] [PubMed] [Green Version]
- Islam, B.; Islam, Z.; GeurtsvanKessel, C.H.; Jahan, I.; Endtz, H.P.; Mohammad, Q.D.; Jacobs, B.C. Guillain-Barre syndrome following varicella-zoster virus infection. Eur. J. Clin. Microbiol. Infect. Dis. 2018, 37, 511–518. [Google Scholar] [CrossRef] [PubMed]
- Gilden, D.H.; Wright, R.R.; Schneck, S.A.; Gwaltney, J.M., Jr.; Mahalingam, R. Zoster sine herpete, a clinical variant. Ann. Neurol. 1994, 35, 530–533. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, P.G.E. Zoster sine herpete: It would be rash to ignore it. Neurology 2011, 76, 416–417. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.; Gershon, A.; Silverstein, S.J.; Li, Z.S.; Lungu, O.; Gershon, M.D. Latent and lytic infection of isolated guinea pig enteric and dorsal root ganglia by varicella zoster virus. J. Med. Virol. 2003, 70, S71–S78. [Google Scholar] [CrossRef] [PubMed]
- Gershon, M.; Gershon, A. Varicella-Zoster Virus and the Enteric Nervous System. J. Infect. Dis. 2018, 218 (Suppl. 2), S113–S119. [Google Scholar] [CrossRef] [PubMed]
- Takahashi, M.; Otsuka, T.; Okuno, Y.; Asano, Y.; Yazaki, T.; Isomura, S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974, 2, 1288–1290. [Google Scholar] [CrossRef]
- Gershon, A.A.; Steinberg, S.; Gelb, L.; NIAID-Collaborative-Varicella-Vaccine-Study-Group. Live attenuated varicella vaccine: Efficacy for children with leukemia in remission. JAMA 1984, 252, 355–362. [Google Scholar] [CrossRef] [PubMed]
- Gershon, A.A. Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future? J. Infect. 2017, 74 (Suppl. 1), S27–S33. [Google Scholar] [CrossRef] [Green Version]
- Shaw, J.; Gershon, A.A. Varicella Virus Vaccination in the United States. Viral Immunol. 2017, 31, 96–103. [Google Scholar] [CrossRef] [PubMed]
- Leung, J.; Harpaz, R. Impact of the Maturing Varicella Vaccination Program on Varicella and Related Outcomes in the United States: 1994–2012. J. Pediatr. Infect. Dis. Soc. 2016, 5, 395–402. [Google Scholar] [CrossRef] [PubMed]
- Kawai, K.; Yawn, B.P.; Wollan, P.; Harpaz, R. Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. Clin. Infect. Dis. 2016, 63, 221–226. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Oxman, M.N.; Levin, M.J.; Johnson, G.R.; Schmader, K.E.; Straus, S.E.; Gelb, L.D.; Arbeit, R.D.; Simberkoff, M.; Gershon, A.; Davis, L.E.; et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 2005, 352, 2271–2284. [Google Scholar] [CrossRef] [PubMed]
- Tseng, H.F.; Harpaz, R.; Luo, Y.; Hales, C.M.; Sy, L.S.; Tartof, S.Y.; Bialek, S.; Hecther, R.C.; Jacobsen, S. Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged >/= 60 Years. J. Infect. Dis. 2016, 213, 1872–1875. [Google Scholar] [CrossRef] [PubMed]
- Willis, E.D.; Woodward, M.; Brown, E.; Popmihajlov, Z.; Saddier, P.; Annunziato, P.W.; Halsey, N.; Gershon, A. Herpes zoster vaccine live: A 10year review of post-marketing safety experience. Vaccine 2017, 35, 7231–7239. [Google Scholar] [CrossRef] [PubMed]
- Cunningham, A.L.; Lal, H.; Kovac, M.; Chlibek, R.; Hwang, S.J.; Diez-Domingo, J.; Godeaux, O.; Levin, M.; McElhaney, J.E.; Puig-Barbera, J.; et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. N. Engl. J. Med. 2016, 375, 1019–1032. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lal, H.; Cunningham, A.L.; Godeaux, O.; Chlibek, R.; Diez-Domingo, J.; Hwang, S.J.; Levin, M.J.; McElhaney, J.E.; Poder, A.; Piuog-Barbera, J.; et al. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults. N. Engl. J. Med. 2015, 372, 2087–2096. [Google Scholar] [CrossRef] [PubMed] [Green Version]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kennedy, P.G.E.; Gershon, A.A. Clinical Features of Varicella-Zoster Virus Infection. Viruses 2018, 10, 609. https://doi.org/10.3390/v10110609
Kennedy PGE, Gershon AA. Clinical Features of Varicella-Zoster Virus Infection. Viruses. 2018; 10(11):609. https://doi.org/10.3390/v10110609
Chicago/Turabian StyleKennedy, Peter G. E., and Anne A. Gershon. 2018. "Clinical Features of Varicella-Zoster Virus Infection" Viruses 10, no. 11: 609. https://doi.org/10.3390/v10110609